Literature DB >> 9642216

Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits.

S K Lee1, H J Kim, S Y Na, T S Kim, H S Choi, S Y Im, J W Lee.   

Abstract

Steroid receptor coactivator-1 (SRC-1) specifically bound to the transcription factor AP-1 subunits c-Jun and c-Fos, as demonstrated by the yeast two-hybrid tests and glutathione S-transferase pull down assays. The c-Jun and c-Fos binding sites were localized to the C-terminal subregion of SRC-1 (amino acids 1101-1441) that encompasses the previously described histone acetyltransferase and receptor-binding domains. In mammalian cells, SRC-1, similar to the previous results with CBP-p300 (Arias, J., Alberts, A. S., Brindle, P., Claret, F. X., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-229; Bannister, A. J., and Kouzarides, T. (1995) EMBO J. 14, 4758-4762), potentiated the AP-1-mediated transactivations in a dose-dependent manner and derepressed the mutual inhibitions between nuclear receptors and AP-1. Furthermore, coexpression of p300 further enhanced this SRC-1-potentiated level of transactivations. Thus, we concluded that at least two distinct coactivator molecules may cooperate to regulate AP-1-dependent transactivations and mediate transrepression between AP-1 and nuclear receptors in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642216     DOI: 10.1074/jbc.273.27.16651

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  alphaNAC requires an interaction with c-Jun to exert its transcriptional coactivation.

Authors:  Isabelle Quèlo; Mélanie Hurtubise; René St-Arnaud
Journal:  Gene Expr       Date:  2002

Review 2.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 3.  Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.

Authors:  Christopher Foley; Nicholas Mitsiades
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

Review 4.  Nuclear receptor coregulators are new players in nervous system development and function.

Authors:  Eijun Nishihara; Bert W O'Malley; Jianming Xu
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

5.  Differential use of functional domains by coiled-coil coactivator in its synergistic coactivator function with beta-catenin or GRIP1.

Authors:  Catherine K Yang; Jeong Hoon Kim; Hongwei Li; Michael R Stallcup
Journal:  J Biol Chem       Date:  2005-12-12       Impact factor: 5.157

6.  Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.

Authors:  Edwin Cheung; Mari Luz Acevedo; Philip A Cole; W Lee Kraus
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

7.  SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.

Authors:  Ping Yi; Weiya Xia; Ray-Chang Wu; David M Lonard; Mien-Chie Hung; Bert W O'Malley
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

8.  Peroxide-mediated chromatin remodelling of a nuclear factor kappa B site in the mouse inducible nitric oxide synthase promoter.

Authors:  Junping Wei; Hongtao Guo; Chengjiang Gao; Paul C Kuo
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Combined proteomics and pathways analysis of collecting duct reveals a protein regulatory network activated in vasopressin escape.

Authors:  Ewout J Hoorn; Jason D Hoffert; Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2005-08-03       Impact factor: 10.121

10.  Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury.

Authors:  Mi Jin Lee; Yong Keun Kwak; Kyung Ran You; Byung Ho Lee; Dae Ghon Kim
Journal:  Exp Mol Med       Date:  2009-04-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.